showed that L. rhamnosus alleviated tumor burden in the murine gut cancer models by a CD8+T cell–dependent manner, suggesting that this strain may be used to enhance the anti-tumor immune response in CRC patients and ultimately increase the breadth and efficacy of immunotherapy (Owens et al., 2021). The gene discussed is CD8A; the disease is neoplasm.